DUBLIN, Calif.--(BUSINESS WIRE)--Nearly two decades ago, ZEISS was the first company to introduce optical coherence tomography (OCT) for clinical use in ophthalmology and optometry. The 20 ...
Fully integrated AI decision support tool flags B scans that may require further review, supporting more confident decision making and more efficient patient care. "At ZEISS, we continue to develop ...
CHICAGO & DUBLIN, Calif. & JENA, Germany--(BUSINESS WIRE)--Medical technology provider Carl Zeiss Meditec announced today the introduction of a new family of ZEISS OCT (Optical Coherence Tomography) ...
Hosted on MSN
Zeiss’ AI-driven tool gets CE mark for OCT scans
Zeiss Medical Technology has received CE mark approval for its CIRRUS PathFinder, a clinical support tool that utilises AI to assist in the interpretation of optical coherence tomography (OCT) scans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results